department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Ohio State University Comprehensive Cancer Center · pharmadog

PUBLIC COMPANY

Ohio State University Comprehensive Cancer Center

updated 2mo ago

community read0 votes

pipeline

0

marketed

0

phase 3

0

catalysts ytd

1

approvals ytd

0

recalls ytd

0

Pipeline(0)

no pipeline products on record

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 2 completion (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Ohio State University Comprehensive Cancer Center jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

mentioned in

0news items

entity-linker matched

phase 2 completion

Ohio State University Comprehensive Cancer Center — canakinumab (Phase II Trial Completion)

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase2Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasmsterminatedn=12
phase2Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancerrecruitingn=70
phase2Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLLcompletedn=41
phase1Romidepsin Maintenance After Allogeneic Stem Cell Transplantationcompletedn=23
N/AEMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancercompletedn=50
phase2Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumabcompletedn=6
phase1Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancercompletedn=25
—Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patientscompletedn=146

more trials →

🐶 often sniffed alongside

top 4

tagOncology3 co-mentions · 1 sources
tagPulmonology1 co-mentions · 1 sources
tagNSCLC1 co-mentions · 1 sources
drugcanakinumab1 co-mentions · 1 sources